I am using Intel (INTC) as an example because it is an NFTRH+ item that has still not reached its target of 40+. That target is in doubt with the…
On the other side of the equation from the earlier GDX update, we have the bearish Financials ETF XLF, losing important support today. MACD, RSI and AROON are all down to boot.
Using GDX as a general sector marker, we see the price dropping right down to the former resistance area around 20. That is the first of two notable support areas.
When we first started with the trade setup service, we highlighted two Semiconductor companies; one large (Intel, which has worked out well) and one small (LSCC, which did not work…
The quick recap is that DAKT (Daktronics) had weaker earnings and gross profits due to operational issues and capacity constraints. The result was a hard decline at the end of…
Stock Market to Janet Yellen: "I dare you to talk tough about Fed Funds rates. I double dare you!" SPY is at our NFTRH+ target, which does not mean it…
Frankly, the more unwieldy this hyper frenetic market gets, the less inclination I have to do NFTRH+ updates, because the volatility has a funny way of breaking charts (with associated…
Per the regular update this morning, the EMA 10 (2056) was noted as key resistance on the S&P 500. Translating that to a bear trade on the SPY, we find…
You may have noticed old friend SIMO back in the Roth IRA per NFTRH 319. That was me in essence jumping the gun just a bit on its chart. Silicon…
In light of the dynamics in play in the interest rate market, one might want to watch a sector that favors rising interest rates (the Banks, given ZIRP at the Fed’s discount window) vs. rising yields out along the curve. Even though the curve is dropping, if we assume that banks are funded near 0% their lending out across the curve would have a profit motive.
A snapshot of current daily technicals…
GLD is just above very tentative support. Does not mean much however, until it closes above the SMA 50.
That way I could apply for my Guru card and that rarefied club might finally accept me! 2 Days ago NFTRH+ made a post on Intel (now public), referencing a…
Folks, the market is over loved, unhealthy and... still bullish. As long as that is the case we must accept it. When the technicals turn, so will we. In that…
Understand that these are just two stocks (without highly liquid volumes) that I am interested in for my own reasons and there is a market full of others out there. So these are not recommendations but rather, examples of charts that I look for at year end.
OncoMed (OMED) is held in the IRA as a sort of lottery ticket speculation. I bought it a few weeks ago at just above 19, rode it up and am riding it back down currently. While I sold several other items on the market bounce, I decided to keep this one because little has changed since it was driven to the 40’s last year by a news release that I considered fundamentally valid (for a very speculative specialty pharma/biotech stock that is).